Efficacy and continuability of 675 mg fremanezumab administration over 2 years
{{output}}
Background: Real-world data on the long-term adherence to- and efficacy of fremanezumab 675 mg quarterly dosing remain scarce. Our study evaluated the efficacy of- and patient adherence to 675 mg fremanezumab for episodic migrain... ...
